The protein regulates cell cycle progression by forming complexes with CDK4 or CDK6 kinases to control the G1/S transition and phosphorylate the tumor suppressor protein Rb. Loss-of-function mutations cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 (MPPH3) through autosomal dominant inheritance. The high pLI score (0.99) indicates this gene is highly intolerant to loss-of-function variants, consistent with haploinsufficiency as the disease mechanism.

OMIMResearchSummary from RefSeq, OMIM, UniProt, Mechanism
GOFmechanismADLOEUF 0.231 OMIM phenotype
Clinical SummaryCCND2
🧬
Gene-Disease Validity (ClinGen)
megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.99). One damaged copy is likely sufficient to cause disease.
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint
0.23LOEUF
pLI 0.987
Z-score 3.35
OE 0.00 (0.000.23)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
2.13Z-score
OE missense 0.54 (0.450.64)
91 obs / 169.0 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.00 (0.000.23)
00.351.4
Missense OE0.54 (0.450.64)
00.61.4
Synonymous OE0.89
01.21.6
LoF obs/exp: 0 / 13.0Missense obs/exp: 91 / 169.0Syn Z: 0.78
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveCCND2-related megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndromeGOFAD
DN
0.4190th %ile
GOF
0.4381th %ile
LOF
0.65top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · LOEUF 0.23
GOF1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFThe findings were consistent with a gain-of-function effect of the CCND2 mutations, and Mirzaa et al. (2014) suggested that the expansion of neuronal progenitor populations underlies the megalencephaly as well as the polymicrogyria observed in the disorder.PMID:24705253

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

CCND2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold
Clinical Literature
Open Research Assistant →